Morningside Group

Investor type

VC / PE / Family office

Founded

1986

AUM

-

Location

Cambridge, Massachusetts, United States

Investment Ticket

$5-10 m

Investment Stage

Seed Series B Series A

Region of investment

North America Europe Asia
Investor profile last updated: 16 August, 2026

Profile

Morningside Group is a venture capital firm based in Newton, Massachusetts, founded in 1986. The firm is led by a team of 12 professionals with expertise in life sciences, digital health, AI, materials, and technology. Morningside Group is known for its long-term outlook in company-building and its commitment to ethical investment practices. The firm also engages in charitable activities, supporting institutions like the Harvard T.H. Chan School of Public Health and the MIT Morningside Academy for Design.

The firm invests in companies with novel science and technology, focusing on sectors such as life sciences, digital health, and AI. Morningside typically participates in Series A and Series B rounds, with check sizes ranging from $5-10 million. The firm operates globally, tailoring its investments to dynamic market needs. Morningside Group also functions as a family office and engages in growth and expansion investments.

Notable investments by Morningside Group include AdvanCell - drug discovery, Mighty Therapeutics - drug discovery, Dermatic Health - decision/risk analysis, Ampa Health - therapeutic devices, and Valitor - biotechnology. These investments highlight the firm's focus on innovative ventures in the biotechnology and technology sectors.

Industry

HealthTech TravelTech Biotechnology Education Edtech Fashion/Beauty Financial Services Fintech Food and Beverage Foodtech Gaming Healthcare Services Marketing and Advertising Media and Entertainment Other Software Technology Energy AI Life Sciences CleanTech

Morningside Group Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Morningside Ventures Fund IV
Venture Capital (VC)
Biotechnology
Healthcare Services
AI
Life Sciences
CleanTech
Pre-seed
Seed
Series A
North America
Europe
Asia
$5-10 m
November 2015

Contacts

Name
Title
Email
avatar
Anthony Aiudi Investment Professional
Investment Professional
a•••@•••
avatar
Ruoxi (Rosy) Hu Investment Professional
Investment Professional
r•••@•••
Upgrade to see contacts
avatar
CGANZ7g4f2wFcM8d CGANZ7g4f2wFcM8d
CGANZ7g4f2wFcM8d
avatar
CGANZ7g4f2wFcM8d CGANZ7g4f2wFcM8d
CGANZ7g4f2wFcM8d
avatar
CGANZ7g4f2wFcM8d CGANZ7g4f2wFcM8d
CGANZ7g4f2wFcM8d
Investment-team contacts for Morningside Group — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Morningside Group

Morningside Group is a venture capital and private equity firm that also operates as a family office. It backs companies at Seed, Series B and Series A, writing tickets of $5-10 m.
Morningside Group is located in Cambridge, Massachusetts, United States.
Morningside Group was founded in 1986.
Morningside Group invests in companies and startups in HealthTech, TravelTech, Biotechnology, Education, Edtech, Fashion/Beauty, Financial Services, Fintech, Food and Beverage, Foodtech, Gaming, Healthcare Services, Marketing and Advertising, Media and Entertainment, Other, Software, Technology, Energy, AI, Life Sciences, CleanTech.
Morningside Group invests in companies and startups in North America, Europe, Asia.
Morningside Group invests in companies and startups at Seed, Series B, Series A.
Morningside Group usually invests $5-10 m on average.
Morningside Group last fund was created/launched in 2015-11-17
Morningside Group can be reached through its website morningside.com and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Morningside Group — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Morningside Group directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.